Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0580
D

Failure to Notify Responsible Party of Medication Discontinuation

Lampasas, Texas Survey Completed on 04-12-2025

Penalty

Fine: $12,740
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to immediately notify a resident's responsible party (RP) when there was a significant change in treatment, specifically the discontinuation of the medication Ativan, as ordered by the physician. The resident in question had severe cognitive impairment, as indicated by a BIMS score of 7, and diagnoses including anxiety disorder, major depressive disorder, and primary hypertension. Documentation review showed that Ativan was discontinued, but there was no record of the RP being notified of this change. The RP later confirmed in an interview that she was not informed about the discontinuation and would have wanted to know, especially as she lived out of state. Interviews with facility staff, including the ADON, DON, and ADM, confirmed that it was the facility's expectation and policy to notify the RP of such significant changes, but this did not occur. The ADON acknowledged the oversight, and both the DON and ADM reiterated that the RP would not have known about the medication change without being contacted. The facility's policy requires notification of the family or legal representative and physician when there is a significant change in the resident's status or a need to alter treatment, which was not followed in this instance.

An unhandled error has occurred. Reload 🗙